Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it growsLONDON, Feb. 03, 2025 (GLOBE ...

London: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as ...

ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and olde ...

The 15 largest deals announced in the UK during January have been revealed by new Insider research, with the transactions covering a range of sectors.

LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir ...

GSK and the University of Oxford have joined hands to focus on the potential of cancer prevention through vaccination. The ...

How does the US stock market stack up against its UK counterpart and how does their recent performance compare?

In an exclusive poll for City AM, Joanna Hodgson surveys major firms to see if hybrid working is still king in the UK ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications.The ...

Prince Harry surprises fans with a heartfelt video supporting the 2025 WellChild. See what the Duke of Sussex had to say here ...